Selective Intra-arterial Chemotherapy with Floxuridine as Second- or Third-Line Approach in Patients with Unresectable Colorectal Liver Metastases

Author： Samaras Panagiotis  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.18, Iss.7, 2011-07, pp. : 1924-1931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study

By Martin Robert  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 192-198

Springer Publishing Company

Access to resources Recommend Favorite

p53 Mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases

By Khan Z.   Jonas S.   Feldmann K.   Patel H.   Wharton R.   Tarragona A.   Ivison A.   Allen-Mersh T.  

Journal of Cancer Research and Clinical Oncology, Vol. 127, Iss. 11, 2001-11 ,pp. : 675-680

Springer Publishing Company

Access to resources Recommend Favorite

Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy

By Vogl Thomas   Schwarz Wolfram   Eichler Katrin   Hochmuth Kathrin   Hammerstingl Renate   Jacob Ursula   Scheller Albert   Zangos Stephan   Heller Matthias  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 11, 2006-11 ,pp. : 745-755

Springer Publishing Company

Access to resources Recommend Favorite

Does a higher response rate to systemic chemotherapy result in a higher resection rate in patients with initially unresectable colorectal liver metastases?

By Sunakawa Yu  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 1039-1040

Informa Healthcare

Access to resources Recommend Favorite

A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial

By Ychou Marc   Rivoire Michel   Thezenas Simon   Quenet François   Delpero Jean-Robert   Rebischung Christine   Letoublon Christian   Guimbaud Rosine   Francois Eric   Ducreux Michel   Desseigne Françoise   Fabre Jean-Michel   Assenat Eric  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4289-4297

Springer Publishing Company

Access to resources Recommend Favorite